Literature DB >> 24647392

High-refined-carbohydrate and high-fat diets induce comparable hepatic tumorigenesis in male mice.

Blanche C Ip1, Chun Liu, Donald E Smith, Lynne M Ausman, Xiang-Dong Wang.   

Abstract

Previous studies demonstrated that diet-induced obese mice fed a semi-purified high-fat diet (HFD) had greater liver tumorigenesis than mice fed a non-semi-purified diet. Because ingredients present in standard unpurified diets may elicit potential chemopreventive properties that are not present in semi-purified diets, the present study evaluated hepatic tumorigenic effects of dietary fat by replacing it with refined carbohydrates [digestible saccharides; high-carbohydrate diet (HCD)] in a semi-purified diet without altering other components. Two-wk-old C57Bl/6J male mice were randomly injected i.p. with either the liver-specific carcinogen diethylnitrosamine (25 mg/kg body weight) to induce liver cancer or saline as the nontumor control. At age 6 wk, mice with or without cancer initiation were further randomly assigned to an HFD (26% and 60% energy from carbohydrates and fat, respectively) or an HCD (66% and 12% energy from carbohydrates and fat, respectively) and consumed food ad libitum for 24 wk. Results showed that HCD-fed mice had a comparable degree of hepatic tumorigenesis (tumor number and volume) as HFD-fed mice, despite having significantly reduced body weights. HCD feeding induced greater hepatic endoplasmic reticulum (ER) stress-mediated protein kinase RNA-activated-like kinase (PERK) activation and oncogenic interleukin-6/signal transducer and activator of transcription 3 signaling than HFD feeding. HCD-stimulated PERK signaling was associated with elevated expression of prosurvival markers in tumors, including induced protein kinase B activation, increased extracellular signal-regulated kinases 1/2 phosphorylation, and elevated cyclin D1 protein expression. However, HCD-mediated PERK activation in tumors was also positively associated with markers of proapoptosis, which included elevated CCAAT/enhancer-binding protein homology protein expression and increased cleaved caspase-3. HCD-fed mice had greater severity in hepatic steatosis than HFD-fed mice. HCD-induced steatosis exacerbation was associated with increased expression in hepatic de novo lipogenic markers that can promote ER stress. Together, these data indicated that chronic HCD consumption by mice can produce comparable severity of hepatic tumorigenesis as HFD consumption, potentially through upregulating PERK-mediated ER stress.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24647392      PMCID: PMC3985820          DOI: 10.3945/jn.113.189613

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  35 in total

1.  Akt determines cell fate through inhibition of the PERK-eIF2α phosphorylation pathway.

Authors:  Zineb Mounir; Jothi Latha Krishnamoorthy; Shuo Wang; Barbara Papadopoulou; Shirley Campbell; William J Muller; Maria Hatzoglou; Antonis E Koromilas
Journal:  Sci Signal       Date:  2011-09-27       Impact factor: 8.192

Review 2.  Obesity, inflammation, and liver cancer.

Authors:  Beicheng Sun; Michael Karin
Journal:  J Hepatol       Date:  2011-11-25       Impact factor: 25.083

3.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

Review 4.  Endoplasmic reticulum stress in liver disease.

Authors:  Harmeet Malhi; Randal J Kaufman
Journal:  J Hepatol       Date:  2010-11-13       Impact factor: 25.083

Review 5.  Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

Authors:  György Baffy; Elizabeth M Brunt; Stephen H Caldwell
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

6.  Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy.

Authors:  Virginia Hernández-Gea; Moira Hilscher; Raphael Rozenfeld; Maribel P Lim; Natalia Nieto; Sabine Werner; Lakshmi A Devi; Scott L Friedman
Journal:  J Hepatol       Date:  2013-02-26       Impact factor: 25.083

7.  Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans.

Authors:  V Fedirko; A Lukanova; C Bamia; A Trichopolou; E Trepo; U Nöthlings; S Schlesinger; K Aleksandrova; P Boffetta; A Tjønneland; N F Johnsen; K Overvad; G Fagherazzi; A Racine; M C Boutron-Ruault; V Grote; R Kaaks; H Boeing; A Naska; G Adarakis; E Valanou; D Palli; S Sieri; R Tumino; P Vineis; S Panico; H B As Bueno-de-Mesquita; P D Siersema; P H Peeters; E Weiderpass; G Skeie; D Engeset; J R Quirós; R Zamora-Ros; M J Sánchez; P Amiano; J M Huerta; A Barricarte; D Johansen; B Lindkvist; M Sund; M Werner; F Crowe; K T Khaw; P Ferrari; I Romieu; S C Chuang; E Riboli; M Jenab
Journal:  Ann Oncol       Date:  2012-11-02       Impact factor: 32.976

8.  Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice.

Authors:  Blanche C Ip; Kang-Quan Hu; Chun Liu; Donald E Smith; Martin S Obin; Lynne M Ausman; Xiang-Dong Wang
Journal:  Cancer Prev Res (Phila)       Date:  2013-10-01

Review 9.  The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling.

Authors:  Suneng Fu; Steven M Watkins; Gökhan S Hotamisligil
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

10.  Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance.

Authors:  Lu-Ping Ren; Stanley M H Chan; Xiao-Yi Zeng; D Ross Laybutt; Tristan J Iseli; Ruo-Qiong Sun; Edward W Kraegen; Gregory J Cooney; Nigel Turner; Ji-Ming Ye
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

View more
  7 in total

1.  Lycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in β-carotene-9',10'-oxygenase knockout male mice.

Authors:  Blanche C Ip; Chun Liu; Alice H Lichtenstein; Johannes von Lintig; Xiang-Dong Wang
Journal:  J Nutr       Date:  2014-12-10       Impact factor: 4.798

2.  Dietary Cyanidin-3-Glucoside Attenuates High-Fat-Diet-Induced Body-Weight Gain and Impairment of Glucose Tolerance in Mice via Effects on the Hepatic Hormone FGF21.

Authors:  Lili Tian; Hongmei Ning; Weijuan Shao; Zhuolun Song; Yasaman Badakhshi; Wenhua Ling; Burton B Yang; Patricia L Brubaker; Tianru Jin
Journal:  J Nutr       Date:  2020-08-01       Impact factor: 4.798

3.  High Starch in Diet Leads to Disruption of Hepatic Glycogen Metabolism and Liver Fibrosis in Largemouth Bass (Micropterus salmoides), Which is Mediated by the PI3K/Akt Signaling Pathway.

Authors:  Liang Zhong; Hongli Liu; Haiqi Zhang; Weidong Zhang; Minghao Li; Ya Huang; Jiayun Yao; Xiaoli Huang; Yi Geng; Defang Chen; Ping Ouyang; Shiyong Yang; Wei Luo; Lizi Yin
Journal:  Front Physiol       Date:  2022-05-23       Impact factor: 4.755

Review 4.  A framework for examining how diet impacts tumour metabolism.

Authors:  Evan C Lien; Matthew G Vander Heiden
Journal:  Nat Rev Cancer       Date:  2019-09-17       Impact factor: 60.716

5.  Population insight of the relationship between lifestyle and cancer: A population-based survey.

Authors:  Fawaz Dabea Alshammari; Hussain Gadelkarim Ahmed; Dena Alshammari; Ahmed Mulfy Alharbi; Atif Saud Alsaedi; Abdulbaset Elasbaly
Journal:  AIMS Public Health       Date:  2019-01-23

6.  Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice.

Authors:  Xinli Li; Chun Liu; Blanche C Ip; Kang-Quan Hu; Donald E Smith; Andrew S Greenberg; Xiang-Dong Wang
Journal:  J Exp Clin Cancer Res       Date:  2015-11-11

7.  Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice.

Authors:  Xinli Li; Fuzhi Lian; Chun Liu; Kang-Quan Hu; Xiang-Dong Wang
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.